Product Information

GLYCOPYRROLATE 0.2 MG/ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $1.6306 per ML under NDC 65219080101. Its NADAC has been published 101 times since Dec 18, 2024.

FDA first approved this application on Oct 27, 2017. Its Orange Book therapeutic-equivalence code is AP.

GLYCOPYRROLATE 0.2 MG/ML VIAL

Glycopyrrolate
$1.6306per ML

Strength

.2 mg/mL

NDC

65219080101

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR; INTRAVENOUS

Effective Date

11/18/2026

Active Ingredients

GLYCOPYRROLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA209328

FDA Approved

10/27/2017

TE Code

AP

On Market Since

12/31/2023

Pharmacological Classes

Anticholinergic
Cholinergic Antagonists

Price Statistics

The NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has been published 101 times since Dec 18, 2024, and over the history we have for it it has risen 16.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.6306 per ML
All-time high$1.6306 (Nov 18, 2026)
All-time low$1.2855 (May 20, 2026)
52-week high$1.6306
52-week low$1.2855
Median price$1.5059
Average price$1.4625
Largest weekly change-14.9% (Mar 18, 2026)
Weeks tracked101
Tracking sinceDec 18, 2024

Price History

1W

+3.2%

1M

+7.7%

3M

+10.1%

6M

+26.9%

1Y

+7.7%

3Y

N/A

5Y

N/A

All

+16.7%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GLYCOPYRROLATE 0.2 MG/ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for GLYCOPYRROLATE 0.2 MG/ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $1.6306 per ML (NDC 65219080101), effective Nov 18, 2026.

How has the price of GLYCOPYRROLATE 0.2 MG/ML VIAL changed over time?

Over the history we have for it, the NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has risen 16.7%. It has been tracked across 101 weekly CMS publications since Dec 18, 2024.

What are the highest and lowest recorded NADAC prices for GLYCOPYRROLATE 0.2 MG/ML VIAL?

Since Dec 18, 2024, the NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has ranged from a low of $1.2855 (May 20, 2026) to a high of $1.6306 (Nov 18, 2026), with a median of $1.5059 per ML.

Are there cheaper alternatives to GLYCOPYRROLATE 0.2 MG/ML VIAL?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYCOPYRROLATE 0.2 MG/ML VIAL, is $1.5137 per ML — about 7% below GLYCOPYRROLATE 0.2 MG/ML VIAL.

Who manufactures GLYCOPYRROLATE 0.2 MG/ML VIAL?

GLYCOPYRROLATE 0.2 MG/ML VIAL (NDC 65219080101) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.